Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder

Benjamin Morasco, Jonathan P. Duckart, Steven Dobscha

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Patients with chronic non-cancer pain (CNCP) have high rates of substance use disorders (SUD). SUD complicates pain treatment and may lead to worse outcomes. However, little information is available describing adherence to opioid treatment guidelines for CNCP generally, or guideline adherence for patients with comorbid SUD. Objective: Examine adherence to clinical guidelines for opioid therapy over 12 months, comparing patients with SUD diagnoses made during the prior year to patients without SUD. Design: Cohort study. Participants: Administrative data were collected from veterans with CNCP receiving treatment within a Veterans Affairs regional healthcare network who were prescribed chronic opioid therapy in 2008 (n = 5814). Key Results: Twenty percent of CNCP patients prescribed chronic opioid therapy had a prior-year diagnosis of SUD. Patients with SUD were more likely to have pain diagnoses and psychiatric comorbidities. In adjusted analyses, patients with SUD were more likely than those without SUD to have had a mental health appointment (29.7% versus 17.2%, OR = 1.49, 95% CI = 1.26-1.77) and a urine drug screen (UDS) (47.0% versus 18.2%, OR = 3.53, 95% CI = 3.06-4.06) over 12 months. There were no significant differences between groups on receiving more intensive treatment in primary care (63.4% versus 61.0%), long-acting opioids (26.9% versus 26.0%), prescriptions for antidepressants (88.2% versus 85.8%, among patients with depression), or participating in physical therapy (30.6% versus 28.6%). Only 35% of patients with SUD received substance abuse treatment. Conclusions: CNCP patients with SUD were more likely to have mental health appointments and receive UDS monitoring, but not more likely to participate in other aspects of pain care compared to those without SUD. Given data suggesting patients with comorbid SUD may need more intensive treatment to achieve improvements in pain-related function, SUD patients may be at high risk for poor outcomes.

Original languageEnglish (US)
Pages (from-to)965-971
Number of pages7
JournalJournal of General Internal Medicine
Volume26
Issue number9
DOIs
StatePublished - Sep 2011

Fingerprint

Chronic Pain
Opioid Analgesics
Substance-Related Disorders
Guidelines
Pain
Therapeutics
Veterans
Appointments and Schedules
Mental Health
Urine
Guideline Adherence
Drug Monitoring
Mental Disorders
Antidepressive Agents
Prescriptions
Comorbidity
Primary Health Care
Cohort Studies

Keywords

  • chronic pain
  • medical utilization
  • opioids
  • substance use disorder
  • treatment guidelines

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. / Morasco, Benjamin; Duckart, Jonathan P.; Dobscha, Steven.

In: Journal of General Internal Medicine, Vol. 26, No. 9, 09.2011, p. 965-971.

Research output: Contribution to journalArticle

@article{e486c9915ee741429dfee6355de19f2a,
title = "Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder",
abstract = "Background: Patients with chronic non-cancer pain (CNCP) have high rates of substance use disorders (SUD). SUD complicates pain treatment and may lead to worse outcomes. However, little information is available describing adherence to opioid treatment guidelines for CNCP generally, or guideline adherence for patients with comorbid SUD. Objective: Examine adherence to clinical guidelines for opioid therapy over 12 months, comparing patients with SUD diagnoses made during the prior year to patients without SUD. Design: Cohort study. Participants: Administrative data were collected from veterans with CNCP receiving treatment within a Veterans Affairs regional healthcare network who were prescribed chronic opioid therapy in 2008 (n = 5814). Key Results: Twenty percent of CNCP patients prescribed chronic opioid therapy had a prior-year diagnosis of SUD. Patients with SUD were more likely to have pain diagnoses and psychiatric comorbidities. In adjusted analyses, patients with SUD were more likely than those without SUD to have had a mental health appointment (29.7{\%} versus 17.2{\%}, OR = 1.49, 95{\%} CI = 1.26-1.77) and a urine drug screen (UDS) (47.0{\%} versus 18.2{\%}, OR = 3.53, 95{\%} CI = 3.06-4.06) over 12 months. There were no significant differences between groups on receiving more intensive treatment in primary care (63.4{\%} versus 61.0{\%}), long-acting opioids (26.9{\%} versus 26.0{\%}), prescriptions for antidepressants (88.2{\%} versus 85.8{\%}, among patients with depression), or participating in physical therapy (30.6{\%} versus 28.6{\%}). Only 35{\%} of patients with SUD received substance abuse treatment. Conclusions: CNCP patients with SUD were more likely to have mental health appointments and receive UDS monitoring, but not more likely to participate in other aspects of pain care compared to those without SUD. Given data suggesting patients with comorbid SUD may need more intensive treatment to achieve improvements in pain-related function, SUD patients may be at high risk for poor outcomes.",
keywords = "chronic pain, medical utilization, opioids, substance use disorder, treatment guidelines",
author = "Benjamin Morasco and Duckart, {Jonathan P.} and Steven Dobscha",
year = "2011",
month = "9",
doi = "10.1007/s11606-011-1734-5",
language = "English (US)",
volume = "26",
pages = "965--971",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder

AU - Morasco, Benjamin

AU - Duckart, Jonathan P.

AU - Dobscha, Steven

PY - 2011/9

Y1 - 2011/9

N2 - Background: Patients with chronic non-cancer pain (CNCP) have high rates of substance use disorders (SUD). SUD complicates pain treatment and may lead to worse outcomes. However, little information is available describing adherence to opioid treatment guidelines for CNCP generally, or guideline adherence for patients with comorbid SUD. Objective: Examine adherence to clinical guidelines for opioid therapy over 12 months, comparing patients with SUD diagnoses made during the prior year to patients without SUD. Design: Cohort study. Participants: Administrative data were collected from veterans with CNCP receiving treatment within a Veterans Affairs regional healthcare network who were prescribed chronic opioid therapy in 2008 (n = 5814). Key Results: Twenty percent of CNCP patients prescribed chronic opioid therapy had a prior-year diagnosis of SUD. Patients with SUD were more likely to have pain diagnoses and psychiatric comorbidities. In adjusted analyses, patients with SUD were more likely than those without SUD to have had a mental health appointment (29.7% versus 17.2%, OR = 1.49, 95% CI = 1.26-1.77) and a urine drug screen (UDS) (47.0% versus 18.2%, OR = 3.53, 95% CI = 3.06-4.06) over 12 months. There were no significant differences between groups on receiving more intensive treatment in primary care (63.4% versus 61.0%), long-acting opioids (26.9% versus 26.0%), prescriptions for antidepressants (88.2% versus 85.8%, among patients with depression), or participating in physical therapy (30.6% versus 28.6%). Only 35% of patients with SUD received substance abuse treatment. Conclusions: CNCP patients with SUD were more likely to have mental health appointments and receive UDS monitoring, but not more likely to participate in other aspects of pain care compared to those without SUD. Given data suggesting patients with comorbid SUD may need more intensive treatment to achieve improvements in pain-related function, SUD patients may be at high risk for poor outcomes.

AB - Background: Patients with chronic non-cancer pain (CNCP) have high rates of substance use disorders (SUD). SUD complicates pain treatment and may lead to worse outcomes. However, little information is available describing adherence to opioid treatment guidelines for CNCP generally, or guideline adherence for patients with comorbid SUD. Objective: Examine adherence to clinical guidelines for opioid therapy over 12 months, comparing patients with SUD diagnoses made during the prior year to patients without SUD. Design: Cohort study. Participants: Administrative data were collected from veterans with CNCP receiving treatment within a Veterans Affairs regional healthcare network who were prescribed chronic opioid therapy in 2008 (n = 5814). Key Results: Twenty percent of CNCP patients prescribed chronic opioid therapy had a prior-year diagnosis of SUD. Patients with SUD were more likely to have pain diagnoses and psychiatric comorbidities. In adjusted analyses, patients with SUD were more likely than those without SUD to have had a mental health appointment (29.7% versus 17.2%, OR = 1.49, 95% CI = 1.26-1.77) and a urine drug screen (UDS) (47.0% versus 18.2%, OR = 3.53, 95% CI = 3.06-4.06) over 12 months. There were no significant differences between groups on receiving more intensive treatment in primary care (63.4% versus 61.0%), long-acting opioids (26.9% versus 26.0%), prescriptions for antidepressants (88.2% versus 85.8%, among patients with depression), or participating in physical therapy (30.6% versus 28.6%). Only 35% of patients with SUD received substance abuse treatment. Conclusions: CNCP patients with SUD were more likely to have mental health appointments and receive UDS monitoring, but not more likely to participate in other aspects of pain care compared to those without SUD. Given data suggesting patients with comorbid SUD may need more intensive treatment to achieve improvements in pain-related function, SUD patients may be at high risk for poor outcomes.

KW - chronic pain

KW - medical utilization

KW - opioids

KW - substance use disorder

KW - treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=80052301773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052301773&partnerID=8YFLogxK

U2 - 10.1007/s11606-011-1734-5

DO - 10.1007/s11606-011-1734-5

M3 - Article

VL - 26

SP - 965

EP - 971

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 9

ER -